| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2022 | MMSI Merit Medical Systems Inc | Peterson Neil51 | Chief Operating Officer | Sell | 4,000 | $58.10 | $232,400.00 | -100% | +14.6% | +23.4% | |
| Aug 1, 2022 | RGEN Repligen Corp | Snodgres Jon59 | Chief Financial Officer | Sell | 2,000 | $220.00 | $440,000.00 | -5.1% | -14.1% | -21.4% | |
| Aug 1, 2022 | TMDX Transmedics Group, Inc. | Carey John F | VP Of Operations | Sell | 7,000 | $40.55 | $283,842.00 | -53.5% | +16.0% | +125.8% | |
| Aug 1, 2022 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 38,347 | $22.28 | $854,388.62 | -2.0% | -29.2% | -70.7% | |
| Aug 1, 2022 | Doyle Michael A68 | CFO And Treasurer | Sell | 471 | $17.96 | $8,457.19 | -1.2% | -27.1% | +64.3% | ||
| Jul 29, 2022 | ANGO Angiodynamics Inc | Helsel Dave71 | SVP Global Operations And R&D | Sell | 5,000 | $22.44 | $112,200.00 | -17.3% | -41.3% | -61.9% | |
| Jul 29, 2022 | TMDX Transmedics Group, Inc. | Tobin James R60 | Director | Sell | 48,515 | $39.98 | $1,939,629.70 | -16.1% | +18.9% | +126.1% | |
| Jul 29, 2022 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 13,504 | $40.01 | $540,295.04 | -22.7% | +18.9% | +126.1% | |
| Jul 29, 2022 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 2,300 | $1.02 | $2,352.00 | +4.1% | +1.9% | -18.5% | |
| Jul 29, 2022 | NEOG Neogen Corp | Adent John Edward49 | President &CEO | Buy | 17,500 | $23.07 | $403,725.00 | +43.1% | -44.7% | -0.2% | |
| Jul 28, 2022 | LFWD Lifeward Ltd. | Lind Global Fund II LP47 | 10% Owner | Sell | 161 | $0.99 | $159.39 | - | -5.3% | -27.0% | |
| Jul 28, 2022 | LFWD Lifeward Ltd. | Lind Global Fund II LP47 | 10% Owner | Buy | 161 | $1.03 | $165.83 | - | -5.3% | -27.0% | |
| Jul 27, 2022 | ISRG Intuitive Surgical Inc | Curet Myriam56 | EVP &Chief Medical Officer | Sell | 9,000 | $225.00 | $2,025,000.00 | -97.6% | +5.6% | +43.6% | |
| Jul 27, 2022 | PEN Penumbra Inc | O'Rourke Bridget55 | Director | Sell | 88 | $135.00 | $11,880.00 | -2.2% | +28.6% | +123.3% | |
| Jul 27, 2022 | NEOG Neogen Corp | Borel James C | Director | Buy | 6,500 | $22.70 | $147,528.55 | +123.3% | -48.2% | -4.3% | |
| Jul 27, 2022 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 11,329 | $3.67 | $41,604.62 | -0.9% | -11.1% | -53.8% | |
| Jul 27, 2022 | NEOG Neogen Corp | Tobin James P | Director | Buy | 2,000 | $22.98 | $45,960.00 | +16.7% | -48.2% | -4.3% | |
| Jul 27, 2022 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 3,725 | $2.17 | $8,078.75 | -3.9% | -29.8% | +19.6% | |
| Jul 26, 2022 | ABT Abbott Laboratories | Starks Daniel J | Director | Sell | 50,000 | $109.14 | $5,456,994.11 | -0.4% | -9.5% | +5.1% | |
| Jul 26, 2022 | ABT Abbott Laboratories | Mateus Fernando | Senior Vice President | Sell | 2,457 | $109.05 | $267,942.98 | -14.5% | -9.5% | +5.1% | |
| Jul 26, 2022 | ISRG Intuitive Surgical Inc | Guthart Gary S | President &CEO | Sell | 79,412 | $216.30 | $17,177,053.84 | -59.3% | +1.6% | +51.9% | |
| Jul 26, 2022 | MODD Modular Medical, Inc. | Sheibley Philip Brent55 | Director | Buy | 2,000 | $4.12 | $8,240.00 | +24.6% | -20.4% | -74.9% | |
| Jul 25, 2022 | ABT Abbott Laboratories | Tyler Julie L. | Senior Vice President | Sell | 253 | $109.09 | $27,599.77 | -0.7% | -9.0% | +4.6% | |
| Jul 25, 2022 | DXCM Dexcom Inc | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 1,000 | $83.07 | $83,070.00 | -0.7% | +19.8% | +57.3% | |
| Jul 25, 2022 | STIM Neuronetics, Inc. | Furlong Stephen74 | CFO | Sell | 13,321 | $3.54 | $47,156.34 | -3.3% | -10.7% | -44.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.